Exact Mass: 446.2416744
Exact Mass Matches: 446.2416744
Found 500 metabolites which its exact mass value is equals to given mass value 446.2416744
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Glycinoeclepin A
Isolated from kidney bean roots. Glycinoeclepin A is found in many foods, some of which are green bean, common bean, pulses, and yellow wax bean. Glycinoeclepin A is found in common bean. Glycinoeclepin A is isolated from kidney bean roots.
6beta-hydroxybudesonide
6β-hydroxybudesonide is a metabolite of budesonide. Budesonide is a glucocorticoid steroid for the treatment of asthma and non-infectious rhinitis (including hay fever and other allergies), and for treatment and prevention of nasal polyposis. In addition, it is used for Crohns disease. (Wikipedia)
SR 49498
C25H30N6O2 (446.24301199999996)
SR 49498 is a metabolite of Irbesartan. Sr 49498 belongs to the family of Aromatic Homomonocyclic Compounds. These are aromatic compounds containig only one ring, which is homocyclic.
Acetylstrophanthidin
Tert-butyl (2-{7-[(2S)-3-(4-cyanophenoxy)-2-hydroxypropyl]-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl}ethyl)carbamate
Corticosterone-21-hemisuccinate
Erdafitinib
C25H30N6O2 (446.24301199999996)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EN - Fibroblast growth factor receptor (fgfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Fluocortin butyl
Prednisolone butyrate
6beta-Hydroxydexbudesonide
Trilaciclib
C24H30N8O (446.25424499999997)
6beta-Angeloyloxy-10alpha-hydroxy-10-desoxo-pyrrhopappolide
2-[(E)-3,7-dimethylocta-2,6-dienyl]-5-(6-hydroxy-1-benzofuran-2-yl)-4-(3-methylbut-2-enyl)benzene-1,3-diol|artopetelin B
(1S,2S,4R,5S,7R,8R,9R,10S)-2,4-diangeloxy-9-hydroxyguai-11(13)-en-8,12-olide
2alpha-acetoxy-6alpha-p-methoxybenzoyl-10beta-hydroxy-jaeschkeanadiol
14alpha,15beta-diacetoxy-3alpha-(4-methylsenecioyloxy)-14beta,15alpha,epoxy-alpha-isocedrene|14alpha,15beta-diacetoxy-3alpha-<4-methylsenecioyloxy>-14beta,15alpha,epoxy-alpha-isocedrene
2-[(2E)-3,7-dimethylocta-2,6-dienyl]-2-(3-methylbut-2-enyl)dibenzo[b,f]oxepin-3,7,10-triol|artocarpol E
Tri-Ac-(3beta,16alpha)-3,16,18-Trihydroxyandrost-5-en-17-one
6beta-(beta-2-Methylbutyryloxy)-pyrrhopappolide|6beta--pyrrhopappolide
17,21-Di-Ac-11,17-21-Trihydroxypregn-4-ene-3,20-dione,
3beta,5-Dihydroxy-14,15beta-epoxy-16beta-acetoxy-5beta,14beta-card-20(22)-enolid
3-Angeloyl,7,8-bis-(2-methylbutanoyl) -9,10-Epoxy-P-mentha-1,3,5-triene-3,7,8-triol|7,9-Di-(2-methylbutyryloxy)-8,10-epoxythymol-angelate
2alpha-hydroxy-6alpha-p-methoxybenzoyl-10beta-acetoxy-jaeschkeanadiol
8alpha-angeloyloxy-11alpha-senecioyloxy-6alphaH,7alphaH-guaian-3-en-12,6-olide
(Z)-2-(3-hydroxy-4-(6-methylhept-2-en-2-yl)benzyl)-5-(3-hydroxy-5-methylphenoxy)-3-methylphenol|expansol C
caseabalansin F|rel-(5R,6R,8S,9S,10R,18S,19R)-18,19-diacetoxy-18,19-epoxy-6-methoxycleroda-3,13(16),14-trien-2-one
(Z)-2-(3-hydroxy-4-(6-methylhept-2-en-2-yl)benzyl)-3-(3-hydroxy-5-methylphenoxy)-5-methylphenol|expansol E
1,21-Di-Ac-(1alpha,11beta)-1,11,21-Trihydroxypregn-4-ene-3,20-dione
2beta,8alpha-di-angeloyloxy-10beta-hydroxy-6alphaH,7alphaH-guaian-3-en-12,6-olide
12-hydroxy-3beta,7beta,18alpha-triacetoxy-8,11,13-abietatriene
6,7-Di-Ac,Me ester-(6alpha,7beta,14alphaH)-6,7-Dihydroxy-17-vouacapanoic acid
8beta-angeloyloxy-3beta-(2-methylbutyryloxy)-1beta,10alpha-epoxy-1,10H-constunolide
3beta-angeloyloxy-6beta-(3-methylbutanoyloxy)furanoeremophilan-14-oic acid|3beta-angeloyloxy-6beta-(3-methylbutyryloxy)-furanoeremophilan-15-oic acid
methyl 12(R*),13(S*)-diacetoxy-18-keto-5(Z),8(Z),10(E),14(Z),16(E)-eicosapentaenoate
2-alpha-acetoxy-6-alpha-anisoyloxy-4beta-hydroxy-7alpha,9alpha-epoxy-trans-carotane|ferkuhinin
1alpha-Hydroxy-3beta-isovaleryloxy-6-O-tigloylsteiractinolid
2-O-acetyl-3-O-isobutyryl-4-O-isocaprylglucopyranose
6beta-(2-methylbutyryloxy)-10beta-hydroxy-3alpha,4alpha,15,16-bis-epoxy-8betaH-cleroda-13(16),14-diene-20,12-olide|6beta-<2-methylbutyryloxy>-10beta-hydroxy-3alpha,4alpha,15,16-bis-epoxy-8betaH-cleroda-13(16),14-diene-20,12-olide
Val Thr Ile Asp
Pravastatin sodium
C23H35NaO7 (446.22803600000003)
D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D004791 - Enzyme Inhibitors > D019161 - Hydroxymethylglutaryl-CoA Reductase Inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent C471 - Enzyme Inhibitor > C1655 - HMG-CoA Reductase Inhibitor D009676 - Noxae > D000963 - Antimetabolites Pravastatin sodium (CS-514 sodium) is an HMG-CoA reductase inhibitor against sterol synthesis with IC50 of 5.6 μM. Pravastatin sodium (CS-514 sodium) is an HMG-CoA reductase inhibitor against sterol synthesis with IC50 of 5.6 μM.
5-hydroxy-2,2,6,6-tetramethyl-4-[3-methyl-1-[2,4,6-trihydroxy-3-(2-methylpropanoyl)phenyl]butyl]cyclohex-4-ene-1,3-dione
C25H34O7_7-Formyl-4,6-dihydroxy-6-(hydroxymethyl)-2,5,5,8a-tetramethyl-3,4,4a,5,6,7,8,8a-octahydro-2H,3H-spiro[1-benzofuran-2,1-naphthalen]-7-yl acetate
C25H34O7_7-Formyl-4,7-dihydroxy-6-(hydroxymethyl)-2,5,5,8a-tetramethyl-3,4,4a,5,6,7,8,8a-octahydro-2H,3H-spiro[1-benzofuran-2,1-naphthalen]-6-yl acetate
Ala Phe Ile Pro
Ala Phe Leu Pro
Ala Phe Pro Ile
Ala Phe Pro Leu
Ala Ile Phe Pro
Ala Ile Pro Phe
Ala Lys Gln Thr
Ala Lys Thr Gln
Ala Leu Phe Pro
Ala Leu Pro Phe
Ala Pro Phe Ile
Ala Pro Phe Leu
Ala Pro Ile Phe
Ala Pro Leu Phe
Ala Gln Lys Thr
Ala Gln Thr Lys
Ala Thr Lys Gln
Ala Thr Gln Lys
Asp Gly Lys Lys
Asp Ile Ile Ser
Asp Ile Leu Ser
Asp Ile Ser Ile
Asp Ile Ser Leu
Asp Ile Thr Val
Asp Ile Val Thr
Asp Lys Gly Lys
Asp Lys Lys Gly
Asp Leu Ile Ser
Asp Leu Leu Ser
Asp Leu Ser Ile
Asp Leu Ser Leu
Asp Leu Thr Val
Asp Leu Val Thr
Asp Ser Ile Ile
Asp Ser Ile Leu
Asp Ser Leu Ile
Asp Ser Leu Leu
Asp Thr Ile Val
Asp Thr Leu Val
Asp Thr Val Ile
Asp Thr Val Leu
Asp Val Ile Thr
Asp Val Leu Thr
Asp Val Thr Ile
Asp Val Thr Leu
Glu Ile Ser Val
Glu Ile Val Ser
Glu Leu Ser Val
Glu Leu Val Ser
Glu Ser Ile Val
Glu Ser Leu Val
Glu Ser Val Ile
Glu Ser Val Leu
Glu Thr Val Val
Glu Val Ile Ser
Glu Val Leu Ser
Glu Val Ser Ile
Glu Val Ser Leu
Glu Val Thr Val
Glu Val Val Thr
Phe Ala Ile Pro
Phe Ala Leu Pro
Phe Ala Pro Ile
Phe Ala Pro Leu
Phe Ile Ala Pro
Phe Ile Pro Ala
Phe Leu Ala Pro
Phe Leu Pro Ala
Phe Pro Ala Ile
Phe Pro Ala Leu
Phe Pro Ile Ala
Phe Pro Leu Ala
Gly Asp Lys Lys
Gly Gly Lys Trp
Gly Gly Trp Lys
Gly Lys Asp Lys
Gly Lys Gly Trp
Gly Lys Lys Asp
Gly Lys Trp Gly
Gly Trp Gly Lys
Gly Trp Lys Gly
His Pro Pro Pro
Ile Ala Phe Pro
Ile Ala Pro Phe
Ile Asp Ile Ser
Ile Asp Leu Ser
Ile Asp Ser Ile
Ile Asp Ser Leu
Ile Asp Thr Val
Ile Asp Val Thr
Ile Glu Ser Val
Ile Glu Val Ser
Ile Phe Ala Pro
Ile Phe Pro Ala
Ile Ile Asp Ser
Ile Ile Ser Asp
Ile Leu Asp Ser
Ile Leu Ser Asp
Ile Pro Ala Phe
Ile Pro Phe Ala
Ile Ser Asp Ile
Ile Ser Asp Leu
Ile Ser Glu Val
Ile Ser Ile Asp
Ile Ser Leu Asp
Ile Ser Val Glu
Ile Thr Asp Val
Ile Thr Val Asp
Ile Val Asp Thr
Ile Val Glu Ser
Ile Val Ser Glu
Ile Val Thr Asp
Lys Ala Gln Thr
Lys Ala Thr Gln
Lys Asp Gly Lys
Lys Asp Lys Gly
Lys Gly Asp Lys
Lys Gly Gly Trp
Lys Gly Lys Asp
Lys Gly Trp Gly
Lys Lys Asp Gly
Lys Lys Gly Asp
Lys Asn Ser Val
Lys Asn Val Ser
Lys Gln Ala Thr
Lys Gln Thr Ala
Lys Ser Asn Val
Lys Ser Val Asn
Lys Thr Ala Gln
Lys Thr Gln Ala
Lys Val Asn Ser
Lys Val Ser Asn
Lys Trp Gly Gly
Leu Ala Phe Pro
Leu Ala Pro Phe
Leu Asp Ile Ser
Leu Asp Leu Ser
Leu Asp Ser Ile
Leu Asp Ser Leu
Leu Asp Thr Val
Leu Asp Val Thr
Leu Glu Ser Val
Leu Glu Val Ser
Leu Phe Ala Pro
Leu Phe Pro Ala
Leu Ile Asp Ser
Leu Ile Ser Asp
Leu Leu Asp Ser
Leu Leu Ser Asp
Leu Pro Ala Phe
Leu Pro Phe Ala
Leu Ser Asp Ile
Leu Ser Asp Leu
Leu Ser Glu Val
Leu Ser Ile Asp
Leu Ser Leu Asp
Leu Ser Val Glu
Leu Thr Asp Val
Leu Thr Val Asp
Leu Val Asp Thr
Leu Val Glu Ser
Leu Val Ser Glu
Leu Val Thr Asp
Met Ile Ile Ala
Met Ile Leu Ala
Met Leu Ala Ile
Met Leu Ala Leu
Met Leu Ile Ala
Met Leu Leu Ala
Met Val Val Val
Asn Lys Ser Val
Asn Lys Val Ser
Asn Ser Lys Val
Asn Ser Val Lys
Asn Val Lys Ser
Asn Val Ser Lys
Pro Ala Phe Ile
Pro Ala Phe Leu
Pro Ala Ile Phe
Pro Ala Leu Phe
Pro Phe Ala Ile
Pro Phe Ala Leu
Pro Phe Ile Ala
Pro Phe Leu Ala
Pro His Pro Pro
Pro Ile Ala Phe
Pro Ile Phe Ala
Pro Leu Ala Phe
Pro Leu Phe Ala
Pro Pro His Pro
Pro Pro Pro His
Gln Ala Lys Thr
Gln Ala Thr Lys
Gln Lys Ala Thr
Gln Lys Thr Ala
Gln Thr Ala Lys
Gln Thr Lys Ala
Ser Asp Ile Ile
Ser Asp Ile Leu
Ser Asp Leu Ile
Ser Asp Leu Leu
Ser Glu Ile Val
Ser Glu Leu Val
Ser Glu Val Ile
Ser Glu Val Leu
Ser Ile Asp Ile
Ser Ile Asp Leu
Ser Ile Glu Val
Ser Ile Ile Asp
Ser Ile Leu Asp
Ser Ile Val Glu
Ser Lys Asn Val
Ser Lys Val Asn
Ser Leu Asp Ile
Ser Leu Asp Leu
Ser Leu Glu Val
Ser Leu Ile Asp
Ser Leu Leu Asp
Ser Leu Val Glu
Ser Asn Lys Val
Ser Asn Val Lys
Ser Val Glu Ile
Ser Val Glu Leu
Ser Val Ile Glu
Ser Val Lys Asn
Ser Val Leu Glu
Ser Val Asn Lys
Thr Ala Lys Gln
Thr Ala Gln Lys
Thr Asp Ile Val
Thr Asp Leu Val
Thr Asp Val Ile
Thr Asp Val Leu
Thr Glu Val Val
Thr Ile Asp Val
Thr Ile Val Asp
Thr Lys Ala Gln
Thr Lys Gln Ala
Thr Leu Asp Val
Thr Leu Val Asp
Thr Gln Ala Lys
Thr Gln Lys Ala
Thr Val Asp Ile
Thr Val Asp Leu
Thr Val Glu Val
Thr Val Ile Asp
Thr Val Leu Asp
Thr Val Val Glu
Val Cys Ile Ile
Val Cys Ile Leu
Val Cys Leu Ile
Val Cys Leu Leu
Val Asp Ile Thr
Val Asp Leu Thr
Val Asp Thr Ile
Val Asp Thr Leu
Val Glu Ile Ser
Val Glu Leu Ser
Val Glu Ser Ile
Val Glu Ser Leu
Val Glu Thr Val
Val Glu Val Thr
Val Ile Cys Ile
Val Ile Cys Leu
Val Ile Asp Thr
Val Ile Glu Ser
Val Ile Ile Cys
Val Ile Leu Cys
Val Ile Ser Glu
Val Ile Thr Asp
Val Lys Asn Ser
Val Lys Ser Asn
Val Leu Cys Ile
Val Leu Cys Leu
Val Leu Asp Thr
Val Leu Glu Ser
Val Leu Ile Cys
Val Leu Ser Glu
Val Leu Thr Asp
Val Asn Lys Ser
Val Asn Ser Lys
Val Ser Glu Ile
Val Ser Glu Leu
Val Ser Ile Glu
Val Ser Lys Asn
Val Ser Leu Glu
Val Ser Asn Lys
Val Thr Asp Ile
Val Thr Asp Leu
Val Thr Glu Val
Val Thr Leu Asp
Val Thr Val Glu
Val Val Glu Thr
Val Val Thr Glu
Trp Gly Gly Lys
Trp Gly Lys Gly
Trp Lys Gly Gly
ethyl-1-(2,4,6-trihydroxy-3-isobutyrylphenyl)butyl]-4-cyclohexene-1,3-dione
acetylstrophanthidin
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D013328 - Strophanthins Strophanidin acetylated at the 3beta-hydroxy group.
4,8-Bis[(2-ethylhexyl)oxy]benzo[1,2-b:4,5-b]dithiophene
C26H38O2S2 (446.23130879999997)
2,3-Bis(n-octylthio)-1,4-naphthalenedione
C26H38O2S2 (446.23130879999997)
(S)-(-)-2,2-Bis(di-i-propylphosphino)-6,6-dimethoxy-1,1-biphenyl,min.
(6,6-Dimethoxy-2,2-biphenyldiyl)bis(diisopropylphosphine)
Disodium 1-[2-(carboxymethoxy)ethyl]-1-(carboxymethyl)-4,5-dihydro-2-undecyl-1H-imidazolium hydroxide
1-pentanoylamino-cyclopentanecarboxylic acid [2-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide
C25H30N6O2 (446.24301199999996)
Trilaciclib
C24H30N8O (446.25424499999997)
V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AF - Detoxifying agents for antineoplastic treatment C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
N2-(2-Ethoxy-4-(4-methyl-4H-1,2,4-triazol-3-yl)phenyl)-6-methyl-N8-neopentylpyrido[3,4-d]pyrimidine-2,8-diamine
C24H30N8O (446.25424499999997)
tert-butyl N-[2-[7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-9-oxa-3,7-diazabicyclo[3.3.1]nonan-3-yl]ethyl]carbamate
N2-(L-Phenylalanyl)-N1-(naphthalenyl)-L-arigninamide
C25H30N6O2 (446.24301199999996)
Fluocortin butyl
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D003879 - Dermatologic Agents
2-[3-Methyl-4-(N-methyl-guanidino)-butyrylamino]-3-(4-phenylethynyl-phenyl)-propionic acid methyl ester
C26H30N4O3 (446.23177899999996)
Erdafitinib
C25H30N6O2 (446.24301199999996)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EN - Fibroblast growth factor receptor (fgfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
(2S)-2-azaniumyl-5-[[(2R)-1-(carboxylatomethylamino)-3-decylsulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoate
C20H36N3O6S- (446.23246960000006)
[11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-1-yl] butanoate
2-[4-(1,3-Benzodioxol-5-ylmethyl)-1-piperazinyl]-1-(8-methyl-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)ethanone
C26H30N4O3 (446.23177899999996)
N-[3-[4-(2,3-dimethylphenyl)-1-piperazinyl]-3-oxopropyl]-2-(1-oxo-2-isoquinolinyl)acetamide
C26H30N4O3 (446.23177899999996)
2-[(3S,6aR,8R,10aR)-1-(1,3-benzodioxol-5-ylmethyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
Asp-Leu-Leu-Ser
A tetrapeptide composed of L-aspartic acid, two L-leucine units and L-serine joined in sequence by peptide linkages.
2-[(3S,6aS,8R,10aS)-1-(1,3-benzodioxol-5-ylmethyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
2-[(3R,6aR,8R,10aR)-1-(1,3-benzodioxol-5-ylmethyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-piperidin-1-ylethanone
2-[(3S,6aR,8S,10aR)-1-(1,3-benzodioxol-5-ylmethyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
(3R,4Z,12R,15S)-17-Tert-butyl-14-(3-hydroxypropyl)-8-methyl-2,9-dioxa-14,17-diazatetracyclo[10.8.0.01,15.03,11]icosa-4,19-diene-10,13,16-trione
1-(1,3-benzodioxol-5-yl)-3-[(2S,3S,6S)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(1,3-benzodioxol-5-yl)-3-[(2S,3S,6R)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
2-[(3R,6aR,8S,10aR)-1-(1,3-benzodioxol-5-ylmethyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
2-[(3R,6aS,8S,10aS)-1-(1,3-benzodioxol-5-ylmethyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
2-[(3S,6aS,8S,10aS)-1-(1,3-benzodioxol-5-ylmethyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
2-cyclopropyl-1-[(1S)-1-(hydroxymethyl)-7-methoxy-1-(3-pyridinylmethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]ethanone
C26H30N4O3 (446.23177899999996)
1-(1,3-benzodioxol-5-yl)-3-[(2S,3R,6S)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(1,3-benzodioxol-5-yl)-3-[(2R,3S,6R)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(1,3-benzodioxol-5-yl)-3-[(2S,3R,6R)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(1,3-benzodioxol-5-yl)-3-[(2R,3R,6R)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(1,3-benzodioxol-5-yl)-3-[(2R,3S,6S)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(1,3-benzodioxol-5-yl)-3-[(2R,3R,6S)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
2-[(2R,4aR,12aS)-5-methyl-6-oxo-8-[[oxo-(propan-2-ylamino)methyl]amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-propylacetamide
2-[(3R,6aS,8R,10aS)-1-(1,3-benzodioxol-5-ylmethyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
2-cyclopropyl-1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-(2-pyridinylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]ethanone
C26H30N4O3 (446.23177899999996)
2-cyclopropyl-1-[(1R)-1-(hydroxymethyl)-7-methoxy-1-(3-pyridinylmethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]ethanone
C26H30N4O3 (446.23177899999996)
2-cyclopropyl-1-[(1S)-1-(hydroxymethyl)-7-methoxy-2-(2-pyridinylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]ethanone
C26H30N4O3 (446.23177899999996)
2-[1-(2-Hydroxy-3,3,5,5-tetramethyl-4,6-dioxo-1-cyclohexenyl)-3-methylbutyl]-4-(2-methylpropanoyl)benzene-1,3,5-triol
[(4E,8E,12E)-2-acetamido-3-hydroxytetradeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
sodium;(3R,5R)-7-[(1R,2S,6S,8R,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate
C23H35NaO7 (446.22803600000003)